As of April 29, 2025, NanoViricides (NNVC) has a market cap of $20.959 million USD. According to our data, NanoViricides is ranked No.8548 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $20.96 M |
2.16%
|
Dec 31, 2024 | $20.52 M |
40.20%
|
Dec 29, 2023 | $14.63 M |
-8.11%
|
Dec 30, 2022 | $15.93 M |
-70.16%
|
Dec 31, 2021 | $53.37 M |
29.62%
|
Dec 31, 2020 | $41.18 M |
14.34%
|
Dec 31, 2019 | $36.01 M |
-37.25%
|
Dec 31, 2018 | $57.39 M |
-77.27%
|
Dec 29, 2017 | $0.25 B |
-17.76%
|
Dec 30, 2016 | $0.31 B |
-9.32%
|
Dec 31, 2015 | $0.34 B |
-56.62%
|
Dec 31, 2014 | $0.78 B |
-43.33%
|
Dec 31, 2013 | $1.38 B |
191.79%
|
Dec 31, 2012 | $0.47 B |
-24.19%
|
Dec 30, 2011 | $0.62 B |
-57.82%
|
Dec 31, 2010 | $1.48 B |
72.94%
|
Dec 31, 2009 | $0.85 B |
4.94%
|
Dec 31, 2008 | $0.81 B |
107.69%
|
Dec 31, 2007 | $0.39 B |
-47.30%
|
Dec 29, 2006 | $0.74 B |
-16.85%
|
Dec 30, 2005 | $0.89 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$25.00 B |
0.001 M
|
![]() Germany
|
![]() Vir Biotechnology
VIR
|
$0.83 B |
-0.000 M
|
![]() USA
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Inovio Pharmaceuticals
INO
|
$70.05 M |
0.000 M
|
![]() USA
|
![]() Arcturus Therapeutics
ARCT
|
$0.35 B |
0.000 M
|
![]() USA
|
![]() Vaxart
VXRT
|
$97.03 M |
0.000 M
|
![]() USA
|
![]() Dynavax Technologies
DVAX
|
$1.41 B |
-0.000 M
|
![]() USA
|
![]() Altimmune
ALT
|
$0.39 B |
0.000 M
|
![]() USA
|
![]() Tonix Pharmaceuticals
TNXP
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Atea Pharmaceuticals
AVIR
|
$0.25 B |
0.000 M
|
![]() USA
|
![]() Ocugen
OCGN
|
$0.21 B |
-0.000 M
|
![]() USA
|
Market Cap | = | NNVC Stock Price | * | NNVC Shares Outstanding |
= | $1.34 | * | 15.64 M | |
= | $20.96 M |